scholarly journals Sphenopalatine ganglion block for ipsilateral shoulder pain following open pancreaticoduodenectomy

2022 ◽  
Vol 15 (1) ◽  
pp. e243746
Author(s):  
Danielle Levin ◽  
Martin Acquadro ◽  
Joseph Cerasuolo ◽  
Frederic Gerges
Keyword(s):  
Shoulder Pain ◽  
Rating Scale ◽  
Numerical Rating Scale ◽  
Left Shoulder ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Numerical Rating ◽  
Sphenopalatine Ganglion Block ◽  
Incisional Pain ◽  
Open Pancreaticoduodenectomy

A 59-year-old woman underwent an open pancreaticoduodenectomy. Thoracic patient controlled-epidural anaesthesia provided excellent incisional pain relief; however, the patient experienced intractable left shoulder pain (10/10 on the Numerical Rating Scale). To our knowledge, there is no effective established treatment for patients experiencing shoulder pain after an open pancreaticoduodenectomy. The patient’s shoulder pain did not respond to medical management with acetaminophen, ketorolac, lidocaine transdermal patch, oxycodone and hydromorphone. Then, on postoperative day 2, the acute pain service was consulted. Considering that the sphenopalatine ganglion block has been previously reported to be helpful in a number of painful conditions, including shoulder tip pain after thoracic surgery, we offered this treatment to the patient. After just one topical sphenopalatine ganglion block, using a cotton-tipped applicator, the patient’s shoulder pain entirely resolved and did not return. This is the first report of a successful treatment of intractable ipsilateral shoulder pain following an open pancreaticoduodenectomy with transnasal sphenopalatine ganglion block.

scholarly journals The effectiveness of sphenopalatine ganglion blockade in chronic migraine resistant to medical treatment

2021 ◽  
Vol 26 (4) ◽  
pp. 737-741
Author(s):  
Nermin Tepe ◽  
Oktay Faysal Tertemiz
Keyword(s):  
Side Effects ◽  
Medical Treatment ◽  
Chronic Migraine ◽  
Alternative Treatment ◽  
Conventional Therapy ◽  
Rating Scale ◽  
Numerical Rating Scale ◽  
Sphenopalatine Ganglion ◽  
Treatment Methods ◽  
Numerical Rating

Objective: To assess the effectiveness of sphenopalatine ganglion blockade (SPGB) as an alternative treatment for patients with chronic migraine resistant to medical treatment. Methods: In total, 23 patients with chronic migraine resistant to medical treatment underwent 4 sessions of bilateral transnasal SPGB bi-weekly, and the monthly number of headache days, duration, and numerical rating scale (NRS) response results were recorded. Results: Compared with before SPGB, the frequency of migraine attacks per month (23.66 ± 9.8 vs. 10.5 ± 11.9 days), duration of headaches (31.3 ± 16.8 vs. 18.4 ± 9.8 h), and NRS score (9 ± 0.99 vs. 5.1 ± 2.1) all improved significantly (p < 0.05) eight weeks after intervention. Conclusion: Transnasal SPGB is an alternative to conventional therapy because it benefits patients with chronic migraine resistant to medical treatment, is easy to administer, and has few side effects.

scholarly journals Sensori-motor recovery in post-stroke shoulder pain: a correlation study

2020 ◽  
Vol 7 (12) ◽  
pp. 4854
Author(s):  
Ushnish Mukherjee ◽  
Sourav Kundu ◽  
Rachit Gulati ◽  
Pankaj Kumar Mandal
Keyword(s):  
Shoulder Pain ◽  
Upper Limb ◽  
Rating Scale ◽  
Numerical Rating Scale ◽  
Correlation Coefficients ◽  
Correlation Study ◽  
Motor Recovery ◽  
Post Stroke ◽  
Numerical Rating ◽  
Negative Role

Background: The prevalence of pain in affected shoulder among post-stroke patients ranges from 34% to 84%. Numerous theories exist to explain the patho-mechanics behind development of Post-stroke shoulder pain, but its relationship with the sensori-motor recovery of the affected limb is still controversial. This study was conducted to detect the correlation, if any, between post-stroke shoulder pain and sensori-motor recovery of the affected upper limb.  Methods: This observational longitudinal study was conducted on 73 patients of both sexes within the age group of 45-65 years having presentation of post-stroke (duration<6weeks) shoulder pain. Pain intensity was recorded in numerical rating scale (NRS). Sensorimotor recovery of the affected limb was assessed by Fugl- Meyer assessment scale of upper extremity (FMA-UE). Data were collected at the baseline (visit1), at 6 weeks (visit 2), 12 weeks (visit 3) and at the end of the study i.e., 24 weeks (visit 4).  Results: Statistically significant negative correlations were found between severity of pain (assessed with NRS) and sensory-motor recovery (assessed with FMA-UE) on each visit with correlation coefficients (Spearman rho, r) being r=-0.890, p=0.000 on visit1, r=-0.685, p=0.000 on visit2, r=-0.629, p=0.000 on visit3 and r=-0.458, p=0.000 on visit 4.Conclusions: Post-stroke shoulder pain plays a significant negative role in sensori-motor recovery of the affected upper limb requiring early intervention.

The Effect of Sphenopalatine Ganglion Block on the Postoperative Pain in Patients Undergoing Septorhinoplasty

2020 ◽  
Vol 129 (7) ◽  
pp. 722-726
Author(s):  
Nazan Degirmenci ◽  
Abdullah Ozdem ◽  
Harun Uysal ◽  
Pelin Sen ◽  
Erol Senturk ◽  
...  
Keyword(s):  
Postoperative Pain ◽  
Rating Scale ◽  
Control Group ◽  
Average Dose ◽  
Sphenopalatine Ganglion ◽  
Block Group ◽  
Ganglion Block ◽  
Significant Difference ◽  
Sphenopalatine Ganglion Block ◽  
The Difference

Objectives: This study aimed to evaluate the effect of preoperative sphenopalatine ganglion block (SPBG) on the postoperative pain (POP) in patients undergoing septorhinoplasty (SRP). Methods: A retrospective cohort study was performed. A total of 42 patients that had received septorhinoplasty included in the study. The patients that had received SPBG before the surgery included in the Block group (n:20) and the patients that had not received SPBG before the surgery included in the Control group (n:22). POP was questioned with a numeric rating scale (NRS) at the 30th minute (t1), 1st hour (t2), 4th hour (t3), 12th hour (t4), and 24th hour (t5) and noted. The intraoperative details and the dose of the postoperative rescue analgesics were also noted. Results: The average dose of Paracetamol that was used in the postoperative first 24 hours was 500 mg in the Block group and 1363 mg in the Control group, and the difference was statistically significant ( P = .001). The average dose of Tramadol was 0 mg in the Block group and 45 mg in the Control group, and the difference was statistically significant ( P = .001). There was a statistically significant difference among the groups with respect to NRS in the first 24 hours postoperatively ( P < .05). The number of the patients requiring rescue analgesics was lower in the Block group than the Control group. The difference was statistically significant at the t1, t2, and t5 time intervals ( P > .05). Conclusions: Preoperative SPGB is an effective option to reduce POP and the need for rescue analgesics for patients undergoing SRP. Clinical trial number: NCT04020393

scholarly journals The Effect of Ouhyul Herbal Acupuncture Point Injections on Shoulder Pain after Stroke

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Yu-Ri Seo ◽  
Woo-Sang Jung ◽  
Seong-Uk Park ◽  
Sang-Kwan Moon ◽  
Jung-Mi Park ◽  
...  
Keyword(s):  
Shoulder Pain ◽  
Rating Scale ◽  
Numerical Rating Scale ◽  
Acupuncture Point ◽  
Control Group ◽  
Control Groups ◽  
Significant Difference ◽  
Numerical Rating ◽  
Point Injection ◽  
And Control

An effective and safe remedy for shoulder pain is needed as shoulder pain is a common complication of stroke and restricts recovery of patients. This study was carried out to evaluate the effect of Ouhyul herbal acupuncture point injection (O-API) on shoulder pain in patients with stroke. Twenty-four participants with shoulder pain after stroke were recruited and randomized to the O-API and control groups. Treatment was conducted for 2 weeks three times per week. We evaluated the effects of treatment with a numerical rating scale (NRS), painless passive range of motion (PROM) of external shoulder rotation, and the Fugl-Meyer Motor Assessment (FMMA) at baseline, each week, and 1 week after the final treatment. All measures were similar between the O-API and control groups at baseline. The O-API group showed significant improvement on the NRS compared with that in the control group after 2 weeks of treatment, and the treatment effect was maintained until the follow-up period. PROM decreased significantly in both groups, but the reduction was maintained only in the O-API group. No significant difference was observed on the FMMA between the two groups. O-API resulted in significant improvement in shoulder pain after stroke, and its effect was maintained after termination of treatment without any severe side effects.

scholarly journals Real-Time Ultrasound-Guided Stellate Ganglion Block for Migraine: An Observational Study

2021 ◽  
Author(s):  
Jiawei Hou ◽  
Shaofeng Pu ◽  
Junzhen Wu ◽  
Zhiqiang Lu ◽  
Xingguo Xu
Keyword(s):  
Side Effects ◽  
Rating Scale ◽  
Numerical Rating Scale ◽  
Stellate Ganglion ◽  
Stellate Ganglion Block ◽  
Ultrasound Guided ◽  
Ganglion Block ◽  
Numerical Rating

Abstract Objective. To observe whether ultrasound-guided stellate ganglion block (SGB) can effectively relieve migraine pain and improve the quality of migraine patients’ life.Methods. 81 patients with migraines were enrolled in this trial. The patients received SGB with 6 ml of 0.15% ropivacaine once every week for four times. Migraine was assessed with the Migraine Disability Assessment Scale (MIDAS) at baseline and three-months follow-up (Tm). The numerical rating scale (NRS) score at baseline, one day after treatment (Td) and Tm, the frequency of analgesic use in 3 months and the side effects were also recorded at the same time.Results. The NRS score of migraine subjects decreased significantly from 7.0 (2.0) to 3.0 (1.0) at Td and 2.0 (2.0) at Tm (vs baseline, P<0.01). The MIDAS total scores were 14.0 (10.5) at baseline and 7.0 (4.5) at Tm (P<0.001). During the three months, the frequency of analgesic consumption was decreased from 6.2 ± 2.8 to 1.9±1.8. There were no serious side effects. Conclusions. This study confirmed that ultrasound-guided SGB is an effective method to treat migraines. This technique can reduce pain and disability and then improve the quality of life of patients with migraines.

scholarly journals Sphenopalatine Ganglion Block for the Treatment of Acute Migraine Headache

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Mohamed Binfalah ◽  
Eman Alghawi ◽  
Eslam Shosha ◽  
Ali Alhilly ◽  
Moiz Bakhiet
Keyword(s):  
Rating Scale ◽  
Numeric Rating Scale ◽  
Acute Migraine ◽  
Sphenopalatine Ganglion ◽  
Ganglion Block ◽  
Migraine Headaches ◽  
Effective Treatment Modality ◽  
Sphenopalatine Ganglion Block ◽  
Global Impression Of Change ◽  
Numeric Rating

Transnasal sphenopalatine ganglion block is emerging as is an attractive and effective treatment modality for acute migraine headaches, cluster headache, trigeminal neuralgia, and several other conditions. We assessed the efficacy and safety of this treatment using the Sphenocath® device. 55 patients with acute migraine headaches underwent this procedure, receiving 2 ml of 2% lidocaine in each nostril. Pain numeric rating scale (baseline, 15 minutes, 2 hours, and 24 hours) and patient global impression of change (2 hours and 24 hours after treatment) were recorded. The majority of patients became headache-free at 15 minutes, 2 hours, and 24 hours after procedure (70.9%, 78.2%, and 70.4%, resp.). The rate of headache relief (50% or more reduction in headache intensity) was 27.3% at 15 minutes, 20% at 2 hours, and 22.2% at 24 hours. The mean pain numeric rating scale decreased significantly at 15 minutes, 2 hours, and 24 hours, respectively. Most patients rated the results as very good or good. The procedure was well-tolerated with few adverse events. This treatment is emerging as an effective and safe option for management of acute migraine attacks.

scholarly journals Ultrasound-Guided Prolotherapy with Polydeoxyribonucleotide for Painful Rotator Cuff Tendinopathy

2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Kyoungho Ryu ◽  
Dongchan Ko ◽  
Goeun Lim ◽  
Eugene Kim ◽  
Sung Hyun Lee
Keyword(s):  
Rotator Cuff ◽  
Shoulder Pain ◽  
Rating Scale ◽  
Numerical Rating Scale ◽  
Specific Subset ◽  
End Of Treatment ◽  
Scale Scores ◽  
Pain Visual Analog Scale ◽  
Numerical Rating ◽  
Rotator Cuff Tendinopathy

Background. Rotator cuff tendinopathy is a primary cause of shoulder pain and dysfunction. Several effective nonsurgical treatment methods have been described for chronic rotator cuff tendinopathy. Prolotherapy with polydeoxyribonucleotide (PDRN), which consists of active deoxyribonucleotide polymers that stimulate tissue repair, is a nonsurgical regenerative injection that may be a viable treatment option. The objective of this study was to assess the efficacy of PDRN in the treatment of chronic rotator cuff tendinopathy. Method. The records of patients with chronic rotator cuff tendinopathy (n=131) were reviewed retrospectively, and the patients treated with PDRN prolotherapy (n=32) were selected. We measured the main outcome of the shoulder pain and disability index score on a numerical rating scale of average shoulder pain. Results. Compared with baseline data, significant improvements in the shoulder pain and disability index and pain visual analog scale scores were demonstrated at one week after the end of treatment, and at one month and three months later. Conclusions. PDRN prolotherapy may improve the conservative treatment of painful rotator cuff tendinopathy for a specific subset of patients.

Sign in / Sign up

Export Citation Format

Share Document